KBP Biosciences
PrivateLast Round
M&A
Oct 16, 2023
Total Funding Raised
$76M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KBP Biosciences operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in January 2018.
KBP Biosciences is a clinical-stage biotechnology company that focuses on the research, development, and commercialization of small-molecule therapeutics for cardiorenal and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KBP Biosciences Comparables
Compare KBP Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhejiang Jixing Auto Parts Co., Ltd. | 83% | |
| Mineralys Therapeutics | 83% | |
| Tanabe Pharma Corporation | 76% |
For institutional investors. Book with your work email.
KBP Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 16, 2023 | ||||
| Series A | Jan 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
KBP Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bay City Capital | Series A |
| Korea Investment Partners | Series A |
| Shenzhen Sangel Venture Capital | Series A |
| Guoke Jiahe Capital | Series A |
| Ping An Ventures | Series A |
| Advantech Capital | Series A |
| SDIC Venture Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 69% MoM.
- Feb 22, 2025
Accused of failing to disclose crucial clinical trial results for ocedurenone.
For institutional investors. Book with your work email.
KBP Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KBP Biosciences's valuation, stock price, and market status.
Is KBP Biosciences a public or private company?
KBP Biosciences is a private company.
What is the current stock price of KBP Biosciences?
KBP Biosciences is a private company, so its shares have no public market price. Caplight tracks KBP Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KBP Biosciences worth (valuation)?
Valuation information for KBP Biosciences is not publicly available.
Can I buy KBP Biosciences stock?
KBP Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KBP Biosciences's last funding round?
KBP Biosciences's most recent funding round was M&A on October 16, 2023.
Who are the main investors in KBP Biosciences?
Key investors in KBP Biosciences include Advantech Capital, SDIC Venture Capital.
Will KBP Biosciences IPO soon?
No public IPO plans have been announced for KBP Biosciences.
How can I track KBP Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in KBP Biosciences's shares on secondary markets.